Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types (2)
Select products & services
Select solutions
Active Filters (2)
Clear All
1 - 12 of 115 Results
Sort by:
Best Match

Protocol: How to use RediJect D-Luciferin for In Vivo Imaging Studies
Protocol for preparing IVISbrite™ RediJect™ (ready-to-use) D-Luciferin bioluminescent substrate for in vivo imaging applications.

PROTOCOL: IVISbrite™ RediJect™ D-Luciferin Ultra for In Vivo Imaging Studies
Protocol for preparing IVISbrite™ RediJect™ (ready-to-use) D-Luciferin Ultra bioluminescent substrate for in vivo imaging applications.

Research and characterization of bispecific antibodies for cancer immunotherapies
In this literature review, we describe several functional approaches to characterize novel BsAbs targeting immune checkpoints and the tumor necrosis factor (TNF) superfamily, with easy-to-use immunoassays.

Literature review on protein-protein interaction assays for virology research
This literature review reviews recent publications and show the homogeneous assay set-ups used in a variety of different studies. We present the outcomes of each study and how the information gathered could lead to antiviral therapies.

Novel drugs for cancer therapy development with PROTAC
A review of current homogeneous assay applications for PROTACs

Novel drugs for cancer therapy development with PROTAC
A review of current homogeneous assay applications for PROTACs

Expand your horizons with this literature review of multiple sclerosis research studies
Discover this literature review showing how scientists leverage immunoassays to move their research forward. Expand your horizons with experiments and data from published studies that investigate new leads for multiple sclerosis (MS) drug discovery.

Expert interview: recapitulating the blood-brain barrier using in vitro hiPSC models in drug discovery
Better understand the blood-brain barrier for translational research and drug discovery in neurodegenerative diseases.

60 second spotlight: prenatal screening for autosomal trisomies
Quick summary of a prospective 2-center study of 862 twin pregnancies. Compared no-call rate and performance against 16,382 singleton pregnancies.

Biopolymers Codelivering Engineered T Cells and STING Agonists can Eliminate Heterogenous Tumors
Using the IVIS® Spectrum non-invasive preclinical optical system to quantify tumor-specific T cells responses in NFAT-luciferase transgenic mice.

DNA origami elevates the design of multispecific antibodies as cancer therapeutic agents
Publication review highlighting the use of the IVIS™ Lumina X5 optical imaging system and BioLegend Antibodies describe programmable T cell engagers (PTEs), a novel class of agents created with DNA origami, a nanotechnology that allows the precise spatial arrangement of biomolecules. When combined with antibodies, this approach holds great promise to develop specific and effective biomedical nanotherapies for diseases like cancer.

Fibrosis study investigating the role of GPCR signaling in fibrosis development
Discover publications on GPCR signaling pathways involved in fibrotic disorders.


Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.